699
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial

, , , &
Pages 125-133 | Accepted 21 Sep 2011, Published online: 04 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jesse D. Ortendahl, Amanda L. Harmon, Tanya G. K. Bentley & Michael S. Broder. (2017) A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies. Journal of Medical Economics 20:7, pages 767-775.
Read now

Articles from other publishers (5)

Jonas Hermansson & Thomas Kahan. (2017) Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe. PharmacoEconomics 36:2, pages 205-213.
Crossref
Till Keller, Jes-Niels Boeckel, Stefan Groß, Jens Klotsche, Lars Palapies, David Leistner, Lars Pieper, Günnter K. Stalla, Hendrik Lehnert, Sigmund Silber, David Pittrow, Winfried Maerz, Marcus Dörr, Hans-Ulrich Wittchen, Sebastian E. Baumeister, Uwe Völker, Stephan B. Felix, Stefanie Dimmeler & Andreas M. Zeiher. (2017) Improved risk stratification in prevention by use of a panel of selected circulating microRNAs. Scientific Reports 7:1.
Crossref
Zhen-jie Xu, Wei Qi & Yi Liu. (2017) Effect of warm needling plus oral medication on blood lipids in cerebral infarction patients温针灸结合口服药物对脑梗死患者血脂的影响. Journal of Acupuncture and Tuina Science 15:2, pages 115-119.
Crossref
Livio Garattini & Anna Padula. (2017) Cholesterol-lowering drugs: science and marketing. Journal of the Royal Society of Medicine 110:2, pages 57-64.
Crossref
Urban AlehagenLina BensonMagnus EdnerUlf DahlströmLars H. Lund. (2015) Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50%. Circulation: Heart Failure 8:5, pages 862-870.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.